Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy.
Front Cell Dev Biol
; 9: 702579, 2021.
Article
in En
| MEDLINE
| ID: mdl-34368154
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Cell Dev Biol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: